[Treatment of diffuse interstitial pulmonary fibrosis]

At the stage of established pulmonary fibrosis there is no effective treatment. Hence the necessity of an early diagnosis at the "cellular" stage of diffuse interstitial fibrosing pneumopathy, which offers the best chances of improvement under corticosteroid therapy. Current biopathological researches on the dynamic mechanisms of fibrosis (fibrogenesis, fibrolysis) should open therapeutic lines involving cytokines and/or their receptors, including at the stage of gene transcription.